Spinal cord stimulation in cardiovascular disease

Area of Science:

• Neurology
• Pain Management
• Cardiology

Background:

• Ischemic pain conditions, including peripheral vascular disease (PVD) and angina pectoris, present significant challenges in patient management.
• Spinal cord stimulation (SCS) has emerged as a potential therapeutic option for refractory ischemic pain.
• Current treatment paradigms often involve vascular surgery or medical management, with varying success rates.

Purpose of the Study:

• To evaluate the efficacy and safety of spinal cord stimulation (SCS) for managing ischemic pain conditions.
• To compare the response rates of SCS in ischemic pain versus neuropathic pain.
• To assess the role of SCS as an adjunct to conventional treatments for PVD and angina pectoris.

Main Methods:

• Systematic review and analysis of existing studies on SCS for ischemic pain.
• Inclusion of data from prospective randomized trials and clinical observations.
• Evaluation of implantation procedures, including safety, duration, and anesthesia requirements.

Main Results:

• SCS demonstrates high long-term response rates (70%-90%) for ischemic pain, significantly higher than for neuropathic pain (50%-70%).
• SCS implantation is a safe, quick procedure performed under local anesthesia, with over 7000 implants for PVD in Europe.
• Studies indicate SCS is a limb-saving treatment for PVD and effectively reduces myocardial ischemia and anginal pain in angina pectoris patients.

Conclusions:

• Spinal cord stimulation is a highly effective treatment for ischemic pain, particularly rest pain in PVD and refractory angina pectoris.
• SCS serves as a valuable supplementary therapy to vascular surgery and conventional medical treatments.
• The safety profile and efficacy of SCS support its increased utilization for ischemic pain management.